Aristides Capital’s Dorman Products DORM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$367K Buy
2,690
+200
+8% +$23.7K 0.07% 136
2026
Q1
$260K Buy
2,490
+296
+13% +$35.2K 0.06% 125
2025
Q4
$270K Sell
2,194
-12,231
-85% -$1.65M 0.05% 129
2025
Q3
$2.25M Hold
14,425
0.32% 53
2025
Q2
$1.77M Sell
14,425
-2,239
-13% -$272K 0.35% 47
2025
Q1
$2.01M Buy
16,664
+2,239
+16% +$286K 0.59% 39
2024
Q4
$1.87M Buy
14,425
+7,425
+106% +$951K 0.38% 44
2024
Q3
$792K Hold
7,000
0.25% 73
2024
Q2
$640K Hold
7,000
0.18% 102
2024
Q1
$675K Buy
+7,000
New +$603K 0.25% 89

Other funds holding DORM

Aristides Capital's DORM Position: Q2 2026 in Review

Aristides Capital increased its Dorman Products (DORM) stake by 8% in Q2 2026, buying an estimated $23.7K and bringing the position to 2,690 shares worth $367K. The position accounts for 0.07% of the portfolio, ranked #136.

Aristides Capital first reported a position in DORM in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.25M in Q3 2025. 329 funds tracked by Wall St. Rank hold DORM as of Q2 2026.

  • Aristides Capital held 2,690 shares of Dorman Products worth $367K as of Q2 2026.
  • Aristides Capital bought 200 Dorman Products shares in Q2 2026, an estimated $23.7K.
  • Dorman Products made up 0.07% of Aristides Capital's portfolio in Q2 2026, its #136 holding.
  • Aristides Capital first reported a position in Dorman Products in Q1 2024 and has held it in 10 quarters since.
  • Aristides Capital's Dorman Products position peaked at $2.25M in Q3 2025.
  • 329 funds tracked by Wall St. Rank held Dorman Products as of Q2 2026.

Based on Aristides Capital's 13F filing for Q2 2026, filed 13 Aug 2026.